These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36452508)

  • 1. High tumor mutation burden indicates better prognosis in colorectal cancer patients with
    Wang J; Song J; Liu Z; Zhang T; Liu Y
    Front Oncol; 2022; 12():1015308. PubMed ID: 36452508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer.
    Xue D; Peng H; Li Z; Xu J; Ma H; Dang Y; Li F; Wang G; Sun Q
    J Cancer; 2024; 15(3):809-824. PubMed ID: 38213725
    [No Abstract]   [Full Text] [Related]  

  • 3. High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Song JP; Liu XZ; Chen Q; Liu YF
    World J Clin Cases; 2022 Jan; 10(3):790-801. PubMed ID: 35127895
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Huang K; Ding S; Chen K; Guo C; Wu M; Zhang R; Wang L; Fu Y; Xiao J; Liu X
    Am J Cancer Res; 2023; 13(11):5549-5558. PubMed ID: 38058823
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing.
    Taflin N; Sandow L; Thawani R; Ye S; Kardosh A; Corless CL; Chen EY
    J Gastrointest Oncol; 2024 Apr; 15(2):681-688. PubMed ID: 38756628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying GNG4 might play an important role in colorectal cancer TMB.
    Zhao H; Sheng D; Qian Z; Ye S; Chen J; Tang Z
    Cancer Biomark; 2021; 32(4):435-450. PubMed ID: 34275892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.
    Lin A; Zhang H; Hu X; Chen X; Wu G; Luo P; Zhang J
    Pharmacol Res; 2020 Sep; 159():105028. PubMed ID: 32569820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and immune infiltration in melanoma patients with different mutation burden.
    Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
    BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
    Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
    Front Genet; 2021; 12():623424. PubMed ID: 33664769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
    Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
    Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
    Cordeiro de Lima VC; Corassa M; Saldanha E; Freitas H; Arrieta O; Raez L; Samtani S; Ramos M; Rojas C; Burotto M; Chamorro DF; Recondo G; Ruiz-Patiño A; Más L; Zatarain-Barrón L; Mejía S; Nicolas Minata J; Martín C; Bautista Blaquier J; Motta Guerrero R; Aliaga-Macha C; Carracedo C; Ordóñez-Reyes C; Garcia-Robledo JE; Corrales L; Sotelo C; Ricaurte L; Santoyo N; Cuello M; Jaller E; Rodríguez J; Archila P; Bermudez M; Gamez T; Russo A; Viola L; Malapelle U; de Miguel Perez D; Rolfo C; Rosell R; Cardona AF
    Lung Cancer; 2022 Aug; 170():114-121. PubMed ID: 35753125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
    Zhang C; Li Z; Qi F; Hu X; Luo J
    Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer.
    Bi F; Chen Y; Yang Q
    Cancer Cell Int; 2020; 20():373. PubMed ID: 32774167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer.
    Du H; Wang H; Kong F; Wu M; Chen W; Lyu J; Zhou S; Yang R
    Front Mol Biosci; 2022; 9():839617. PubMed ID: 35252356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
    Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
    Yan D; Chen Y
    Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis.
    Dai D; Wang Y; Zhu L; Jin H; Wang X
    PeerJ; 2020; 8():e9149. PubMed ID: 32547859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.